Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Synergistic antitumor effect of adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase and nucleoside analogs for human breast carcinoma in vitro and in vivo.

Tang M, Zu C, He A, Wang W, Chen B, Zheng X.

Drug Des Devel Ther. 2015 Jul 14;9:3301-12. doi: 10.2147/DDDT.S81717. eCollection 2015.

2.

Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.

Predina JD, Judy B, Aliperti LA, Fridlender ZG, Blouin A, Kapoor V, Laguna B, Nakagawa H, Rustgi AK, Aguilar L, Aguilar-Cordova E, Albelda SM, Singhal S.

Cancer Gene Ther. 2011 Dec;18(12):871-83. doi: 10.1038/cgt.2011.56. Epub 2011 Aug 26.

3.

Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms.

Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM.

Mol Ther. 2010 Nov;18(11):1947-59. doi: 10.1038/mt.2010.159. Epub 2010 Aug 3.

4.

Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro.

Fontecedro AC, Lutschg V, Eichhoff O, Dummer R, Greber UF, Hemmi S.

Virol J. 2010 Jul 29;7:175. doi: 10.1186/1743-422X-7-175.

5.

Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.

Zheng FQ, Xu Y, Yang RJ, Wu B, Tan XH, Qin YD, Zhang QW.

Acta Pharmacol Sin. 2009 May;30(5):617-27. doi: 10.1038/aps.2009.33. Epub 2009 Apr 13.

6.

Armed replicating adenoviruses for cancer virotherapy.

Cody JJ, Douglas JT.

Cancer Gene Ther. 2009 Jun;16(6):473-88. doi: 10.1038/cgt.2009.3. Epub 2009 Feb 6. Review.

7.

Imaging of viral thymidine kinase gene expression by replicating oncolytic adenovirus and prediction of therapeutic efficacy.

Kim EJ, Yoo JY, Choi YH, Ahn KJ, Lee JD, Yun CO, Yun M.

Yonsei Med J. 2008 Oct 31;49(5):811-8. doi: 10.3349/ymj.2008.49.5.811.

8.

Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter.

Ahn M, Lee SJ, Li X, Jiménez JA, Zhang YP, Bae KH, Mohammadi Y, Kao C, Gardner TA.

Cancer Gene Ther. 2009 Jan;16(1):73-82. doi: 10.1038/cgt.2008.59. Epub 2008 Sep 5.

Supplemental Content

Support Center